164 related articles for article (PubMed ID: 12616334)
1. Subjective effects of the nicotine lozenge: assessment of abuse liability.
Houtsmuller EJ; Henningfield JE; Stitzer ML
Psychopharmacology (Berl); 2003 Apr; 167(1):20-7. PubMed ID: 12616334
[TBL] [Abstract][Full Text] [Related]
2. Flavor improvement does not increase abuse liability of nicotine chewing gum.
Houtsmuller EJ; Fant RV; Eissenberg TE; Henningfield JE; Stitzer ML
Pharmacol Biochem Behav; 2002 Jun; 72(3):559-68. PubMed ID: 12175452
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum.
Stiles MF; Campbell LR; Jin T; Graff DW; Fant RV; Henningfield JE
Psychopharmacology (Berl); 2018 Jul; 235(7):2077-2086. PubMed ID: 29725702
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a nicotine lozenge for smoking cessation.
Shiffman S; Dresler CM; Hajek P; Gilburt SJ; Targett DA; Strahs KR
Arch Intern Med; 2002 Jun; 162(11):1267-76. PubMed ID: 12038945
[TBL] [Abstract][Full Text] [Related]
6. The effect of acute exercise on cigarette cravings while using a nicotine lozenge.
Tritter A; Fitzgeorge L; Prapavessis H
Psychopharmacology (Berl); 2015 Jul; 232(14):2531-9. PubMed ID: 25701265
[TBL] [Abstract][Full Text] [Related]
7. A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation.
Xiao D; Kotler M; Kang J; Wang C
J Addict Med; 2020; 14(1):69-77. PubMed ID: 31658113
[TBL] [Abstract][Full Text] [Related]
8. Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
Marsh HS; Dresler CM; Choi JH; Targett DA; Gamble ML; Strahs KR
Clin Ther; 2005 Oct; 27(10):1571-87. PubMed ID: 16330293
[TBL] [Abstract][Full Text] [Related]
9. Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.
Kotlyar M; Lindgren BR; Vuchetich JP; Le C; Mills AM; Amiot E; Hatsukami DK
Addict Behav; 2017 Aug; 71():18-24. PubMed ID: 28235705
[TBL] [Abstract][Full Text] [Related]
10. The impact of nicotine lozenges and stimulus expectancies on cigarette craving.
Schlagintweit HE; Good KP; Barrett SP
J Psychopharmacol; 2014 Aug; 28(8):773-9. PubMed ID: 24476987
[TBL] [Abstract][Full Text] [Related]
11. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of nicotine lozenge for smokeless tobacco use.
Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
Nicotine Tob Res; 2009 Dec; 11(12):1415-23. PubMed ID: 19880578
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
14. The influence of acutely administered nicotine on cue-induced craving for gambling in at-risk video lottery terminal gamblers who smoke.
McGrath DS; Dorbeck A; Barrett SP
Behav Pharmacol; 2013 Apr; 24(2):124-32. PubMed ID: 23412113
[TBL] [Abstract][Full Text] [Related]
15. Nicotine lozenge efficacy in light smokers.
Shiffman S
Drug Alcohol Depend; 2005 Mar; 77(3):311-4. PubMed ID: 15734231
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a nicotine polacrilex lozenge.
Choi JH; Dresler CM; Norton MR; Strahs KR
Nicotine Tob Res; 2003 Oct; 5(5):635-44. PubMed ID: 14577980
[TBL] [Abstract][Full Text] [Related]
17. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.
Kraiczi H; Hansson A; Perfekt R
Nicotine Tob Res; 2011 Dec; 13(12):1176-82. PubMed ID: 21849415
[TBL] [Abstract][Full Text] [Related]
18. The acute effects of nicotine on the subjective and behavioural responses to denicotinized tobacco in dependent smokers.
Barrett SP; Darredeau C
Behav Pharmacol; 2012 Jun; 23(3):221-7. PubMed ID: 22470104
[TBL] [Abstract][Full Text] [Related]
19. Slow-release L-Cysteine (Acetium®) Lozenge Is an Effective New Method in Smoking Cessation. A Randomized, Double-blind, Placebo-controlled Intervention.
Syrjänen K; Eronen K; Hendolin P; Paloheimo L; Eklund C; Bäckström A; Suovaniemi O
Anticancer Res; 2017 Jul; 37(7):3639-3648. PubMed ID: 28668855
[TBL] [Abstract][Full Text] [Related]
20. Placebo cigarettes in a spaced smoking paradigm.
Eid NC; Fant RV; Moolchan ET; Pickworth WB
Pharmacol Biochem Behav; 2005 May; 81(1):158-64. PubMed ID: 15894074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
